Loading the content... Loading depends on your connection speed!

Shopping Cart - $0.00

Pharmaceutical Drugs Market Global Briefing 2017

Pharmaceutical Drugs Market Global Briefing 2017

From $1,000.00

Including: Cardiovascular Drugs, Musculoskeletal Drugs, Oncology Drugs, Anti-infective Drugs, Metabolic Disorder Drugs, Central Nervous System Drugs, Genito-urinary Drugs, Gastrointestinal Drugs, Respiratory Drugs, Hematology Drugs, Dermatology Drugs, Ophthalmology Drugs.
Covering: Novartis AG, Sanofi S.A., F. Hoffmann-La Roche Ltd, Pfizer Inc., Gilead Sciences, Inc., Johnson & Johnson, GlaxosmithKline Plc., Bayer AG, Teva Pharmaceuticals, Merck & Co.


Clear selection
SKU: 2280. Categories: , .
Description

The segments in the pharmaceutical drugs market include cardiovascular drugs, musculoskeletal drugs, oncology drugs, anti-infective drugs, metabolic disorder drugs, central nervous system drugs, genito-urinary drugs, gastrointestinal drugs, respiratory drugs, hematology drugs, dermatology drugs, ophthalmology drugs.

Pharmaceutical Drugs Market Global Briefing from the Business Research Company covers market characteristics, size and growth, segmentation, regional breakdowns, competitive landscape, market shares, trends and strategies for this market.

The market characteristics section of the report defines and explains the market.

The market size section gives the pharmaceutical drugs market revenues, covering both the historic growth of the market and forecasting the future.

Drivers and restraints looks at the external factors supporting and controlling the growth of the market.

Market segmentations break down the key sub sectors which make up the market. The regional breakdowns section gives the size of the market geographically.

Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in the last three years are identified.

The trends and strategies section highlights the likely future developments in the pharmaceutical drugs market and suggests approaches.

Reasons to Purchase

• Get up to date information available on the pharmaceutical drugs market globally.
• Identify growth segments and opportunities.
• Facilitate decision making on the basis of historic and forecast data and understand the drivers and restraints on the market.
• Develop strategies based on likely future developments.
• Gain a global perspective on the development of the market.

 

Scope

Markets Covered: Cardiovascular Drugs, Musculoskeletal Drugs, Oncology Drugs, Anti-infective Drugs, Metabolic Disorder Drugs, Central Nervous System Drugs, Genito-urinary Drugs, Gastrointestinal Drugs, Respiratory Drugs, Hematology Drugs, Dermatology Drugs, Ophthalmology Drugs.
Companies Mentioned: Novartis AG, Sanofi S.A., F. Hoffmann-La Roche Ltd, Pfizer Inc., Gilead Sciences, Inc., Johnson & Johnson, GlaxosmithKline Plc., Bayer AG, Teva Pharmaceuticals, Merck & Co.
Geographic scope: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa
Time series: Five years historic and forecast.
Data: Market value in $ billions.
Data segmentations: Regional breakdowns, market share of competitors, key sub segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Executive Summary
The pharmaceutical industry develops drugs to diagnose, cure, treat or prevent diseases. Pharmaceutical companies produce both generic and branded drugs. Pharmaceutical drugs are subjected to various laws and regulations that deal with patenting, testing, safety, efficacy and marketing.

Pharmaceutical companies produce pharmaceutical drugs made from active pharmaceutical ingredients (API) and excipients.

The global pharmaceutical drugs market is expected to reach around $1100 billion in 2020.

Early Rx-To-OTC Switch - Early Rx-to-OTC switch, or switching the product from prescription to non-prescription status, is a key trend in the dermatology drugs market. Traditionally, the Rx-to-OTC status conversion was generally observed at a phase nearing the patent expiry or after. However, forward-thinking companies are now looking at switching from Rx-to-OTC well in advance of the patent expiry of the drug. This helps the manufacturer to capitalize on the market opportunities for the product. Early Rx-to-OTC switching also provides an additional benefit as a way to recover all the expenses incurred on the product by the company. A key example from the dermatology OTC drugs market for an early switch includes butenafine hydrochloride (Lotrimin Ultra), an anti-fungal drug. The product was reclassified and switched to being an OTC drug in December 2001, long before its patent expiry (April 2017). It is used in the treatment of athlete’s foot, jock itch and ringworm infections.
Table of Contents
Pharmaceutical Drugs Market Characteristics 5
Pharmaceutical Drugs Market Historic Growth 7
Drivers Of The Market 8
Restraints On The Market 8
Pharmaceutical Drugs Market Forecast Growth 10
Drivers Of The Market 11
Restraints On The Market 11
Pharmaceutical Drugs Market Segmentation 13
Global Pharmaceutical Drugs Market, Split By Segments, 2016, $ Billion 13
Cardiovascular Drugs 14
Musculoskeletal Drugs 14
Oncology Drugs 15
Anti-infective Drugs 15
Metabolic Disorder Drugs 15
Central Nervous System Drugs 15
Genito-urinary Drugs 15
Gastrointestinal Drugs 16
Respiratory Drugs 16
Hematology Drugs 16
Dermatology Drugs 16
Ophthalmology Drugs 16
Global Pharmaceutical Drugs Market, Historic and Forecast, Split By Segments, 2012-2020 17
Pharmaceutical Drugs Market Geography Regional and Country Comparison 20
Global Pharmaceutical Drugs Market, Split By Regions, 2016 20
Global Pharmaceutical Drugs Market, Historic And Forecast Growth Rate, Split By Region, 2012-2020 22
Global Pharmaceutical Drugs Market, Split By Country, 2016 24
Global Pharmaceutical Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2012-2020 26
Pharmaceutical Drugs Market Competitive Landscape 28
Novartis AG 29
Sanofi S.A. 29
Gilead Sciences, Inc. 29
F. Hoffmann-La Roche Ltd 29
Johnson & Johnson 29
Pfizer Inc. 29
Bayer AG 29
GlaxosmithKline Plc. 29
Merck & Co. 29
Teva Pharmaceuticals 29
Novartis 30
Sanofi 30
F.Hoffmann-La Roche 31
Pfizer 31
Pharmaceutical Drugs Market Key Mergers And Acquisitions 33
Actavis Plc. Acquired Allergan Inc. 33
Teva Acquired Allergan’s Generic Business 33
AbbVie Acquired Pharmacyclics 33
Pfizer Acquired Hospira 33
Pfizer Acquired Medivation 34
Bayer Acquired Merck’s Consumer Care Business 34
Valeant Pharmaceuticals International Acquired Salix Pharmaceuticals 34
Endo International plc Acquired Par Pharmaceutical Holdings Inc. 34
Alexion Acquired Synageva 34
Roche Acquired InterMune 34
Celgene Acquired Receptos 34
Shire Acquired Dyax Corp. 34
AbbVie Acquired Stemcentrx 35
ADMA Biologics Acquired Biotest’s Therapy Business 35
Pharmaceutical Drugs Market Trends And Strategies 36
Early Rx-To-OTC Switch 36
Demand For New Medicines For Drug-Resistant Infections 36
Turning Away From Animal Testing 36
Increase In Personalized Medicine 37
Collaboration Driving Innovation 37
Increase in Mergers and Acquisitions 37
Aggressive Pricing Changes in Some Drugs 37
Appendix 38
NAICS Definitions Of Industry Covered In This Report 38
Definition Of Market Covered In This Report 38
Abbreviations 38
Currencies 38
Research Methodology 38
Research Inquiries 39
The Business Research Company 40

List of Figures
Figure 1: Global Pharmaceutical Drugs Market, Historic Market Size, 2012-2016, $ Billion 7
Figure 2: Global Pharmaceutical Drugs Market, Forecast Market Size, 2016 – 2020, $ Billion 10
Figure 3: Global Pharmaceutical Drugs Market, Split By Segments, 2016, $ Billion 13
Figure 4: Global Pharmaceutical Drugs Market, Historic and Forecast, Split By Segment, 2012 – 2020 17
Figure 5: Global Pharmaceutical Drugs Market, Split By Region, 2016, $ Billion 20
Figure 6: Global Pharmaceutical Drugs Market, Historic And Forecast Growth Rate, Split By Region, 2012-2020 22
Figure 7: Global Pharmaceutical Drugs Market, Split By Country, 2016, $ Billion 24
Figure 8: Global Pharmaceutical Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2012-2020 26
Figure 9: Global Pharmaceutical Drugs Market, Key Competitor Market Shares, 2016, Percentage (%) 28

List of Tables
Table 1: Global Pharmaceutical Drugs Market, Historic Market Size, 2012-2016, $ Billion 7
Table 2: Global Pharmaceutical Drugs Market, Forecast Market Size, 2016 – 2020, $ Billion 10
Table 3: Global Pharmaceutical Drugs Market, Split By Segments, 2016, $ Billion 14
Table 4: Global Pharmaceutical Drugs Market, Historic and Forecast, Split By Segment, 2012 – 2020 18
Table 5: Global Pharmaceutical Drugs Market, Split By Region, 2016, $ Billion 21
Table 6: Global Pharmaceutical Drugs Market, Historic And Forecast Growth Rate, Split By Region, 2012-2020 22
Table 7: Global Pharmaceutical Drugs Market, Split By Country, 2016, $ Billion 24
Table 8: Global Pharmaceutical Drugs Market, Historic And Forecast Growth Rate, Split By Country, 2012-2020 26
Table 9: Global Pharmaceutical Drugs Market, Key Competitor Market Shares, 2016, Percentage (%) 29
Get Customized Report
Please fill in your details. Our team will get back to you